Overall Status

Terminated (15)

Completed (8)

Unknown status (2)

Not yet recruiting (1)

Recruiting (1)

Withdrawn (1)

Phase

phase 3 (20)

phase 2 (3)

phase 4 (2)

n/a (1)

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Sanofi (19)

Hospital Nacional de Paraplejicos de Toledo (2)

Aristotle University Of Thessaloniki (1)

Hospital Arnau de Vilanova (1)

National Institute on Drug Abuse (NIDA) (1)

The Scripps Research Institute (1)

University of Maryland, Baltimore (1)

University of Surrey (1)

Weill Medical College of Cornell University (1)

Collaborator

National Institute on Drug Abuse (NIDA) (2)

European Foundation for the Study of Diabetes (1)

National Institutes of Health (NIH) (1)

PWSAUSA (1)

Pfizer (1)

Royal Surrey County Hospital NHS Foundation Trust (1)

Study Documents

Intervention Type

drug (28)

other (2)

behavioral (1)

Funder Type

Industry (19)

Other (8)

NIH (1)

Study Type

Interventional (28)

rimonabant

Showing 26 - 28 of 28

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Obesity, Dyslipidemias Trial in Worldwide (rimonabant, Placebo)

Terminated

Obesity
Dyslipidemias

rimonabant
Placebo

Prague, Czech Republic
+14 more

Dec 9, 2010

Obesity Trial in Guildford (rimonabant, Dietary intervention)

Terminated

Obesity

rimonabant
Dietary intervention

Guildford, Surrey, United Kingdom

Royal Surrey County Hospital

Apr 16, 2010

Atherosclerosis, Cardiovascular Diseases Trial in Lleida (Simvastatin or Atorvastatin, Enalapril, Aspirin or clopidogrel)

Unknown status

Atherosclerosis
Cardiovascular Diseases

Simvastatin or Atorvastatin
+3 more

Lleida, Catalunya, Spain

Hospital Arnau de Vilanova

Aug 13, 2008